About ERELZI

ERELZI is a prescription medication containing the active ingredient Etanercept, a recombinant human tumor necrosis factor (TNF) receptor fusion protein. It is used to treat various inflammatory conditions, including moderate to severe rheumatoid arthritis, psoriatic arthritis, and plaque psoriasis.

Key Benefits & Uses

Treatment of moderate to severe rheumatoid arthritis in adults, reducing symptoms and slowing disease progression.
Treatment of psoriatic arthritis in adults, reducing joint pain and inflammation.
Treatment of plaque psoriasis in adults, reducing inflammation and slowing disease progression.

Active Ingredient & Action

Etanercept works by binding to tumor necrosis factor-alpha (TNF-alpha), a substance in the body that causes inflammation and is involved in autoimmune diseases. By blocking the action of TNF-alpha, Etanercept reduces inflammation and slows disease progression in the treated conditions.

Important Notes

ERELZI is available by prescription only and should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and administration instructions carefully. Common side effects may include injection site reactions, headache, and fatigue. Patients with a history of infections or weakened immune systems should consult their doctor before starting treatment with ERELZI.